Skip to main content

Sigma-Aldrich Pays $2.2M to Cyntellect; Milestone Payment for Cell Xpress Service Agreement

NEW YORK, June 7 (GenomeWeb News) - Cyntellect has received a $2.2 million payment from Sigma-Aldrich as part of its Cell Xpress service agreement, the company said today.


The two companies signed an exclusive commercialization agreement for the Cell Xpress service a year ago when Sigma-Aldrich agreed to employ Cyntellect's Laser Enabled Analysis and Processing system to support its Cell Xpress service business.


Cyntellect received the milestone payment for meeting certain terms and conditions under the agreement, the company said in a statement.


The service enables a high-throughput process for in situ measurement of protein secretion on an individual cell basis, and clones high-producing cells used in manufacturing of biopharmaceuticals and diagnostic antibodies.


Details on further payments were not disclosed.


The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.